Medifast Is Maintained at Underperform by DA Davidson
Medifast Price Target Maintained With a $17.50/Share by DA Davidson
Express News | DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
D.A. Davidson Maintains Medifast(MED.US) With Sell Rating, Maintains Target Price $17.5
D.A. Davidson Sticks to Its Sell Rating for Medifast (MED)
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
Medifast, Inc.'s (NYSE:MED) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Personal Care Stocks Q1 Teardown: Medifast (NYSE:MED) Vs The Rest
Medifast Named as One of The "Best Companies To Work For" by U.S. News & World Report
Are Medifast, Inc. (NYSE:MED) Investors Paying Above The Intrinsic Value?
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24
Krystal Biotech, Virtu, StepStone, Cactus, Tidewater to Join S&P 600
Street Calls of the Week: Upgrades for Best Buy and Lululemon
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Medifast Falls 15% Following DA Davidson Downgrade
Express News | MEDIFAST Shares Are Trading Lower After DA Davidson Downgraded the Stock From Neutral to Underperform and Lowered Its Price Target From $25 to $17.5
Medifast Analyst Ratings
Express News | Medifast Inc : D.a. Davidson Cuts Target Price to $17.5 From $25